Perturbations in multiple components of the PI3K-Akt signaling axis have been observed in numerous tumor types, most notable of which are mutations in or amplifications of PIK3CA, the gene encoding the p110α catalytic subunit of the class I PI3K. The gene discussed is AKT1; the disease is neoplasm.